Analysis of longitudinal laboratory data in the presence of common selection mechanisms: a view toward greater emphasis on pre-marketing pharmaceutical safety.

Schildcrout JS, Jenkins CA, Ostroff JH, Gillen DL, Harrell FE, Trost DC
Stat Med. 2008 27 (12): 2248-66

PMID: 17929332 · DOI:10.1002/sim.3071

MeSH Terms (11)

Biometry Clinical Trials, Phase II as Topic Drug-Related Side Effects and Adverse Reactions Humans Laboratories Longitudinal Studies Marketing Models, Statistical Placebos Randomized Controlled Trials as Topic Selection Bias

Connections (2)

This publication is referenced by other Labnodes entities: